Navigation Links
DVT Risk Increased After Acute Infections

Deep vein thrombosis (DVT) or clot formation is on the rise among patients who suffer from acute illness. The team led by Dr Liam Smeeth, from the London School of Hygiene and Tropical Medicine, //said that they wanted to look at whether infection could trigger DVT or pulmonary embolisms.

The Lancet studied and analyzed the 3 million GPs' records and found 7,278 people suffer from DVT and 3,755 a clot on the lung. The London team found those who had suffered either respiratory or urinary infections were nearly twice as likely to develop blood clots two weeks later. They suggested that the clots could have been caused by inflammation in the blood vessel linked with infection. Statistics show that DVT contributes to about 10% of deaths among hospital patients each year. Usually they occur in the leg veins but can also break off and lodge in the small vessels in the lung.

If this occurs the condition is called a pulmonary embolism. This can be fatal if not treated properly. Participants who had suffered previously from either acute infections in the urinary tract or in the respiratory system such as influenza, bronchitis and pneumonia were studied. They found that during the infection there was no impact on the risk of developing blood clots. But after several weeks the risk appeared to double. Dr Smeeth said that the clot formation could be attributed as an effect of the inflammatory response due to the infection.

DVT has commonly been associated with people sitting still in cramped conditions on aeroplanes and also dehydration associated with the infection could thicken the blood. Hence this risk factor should be considered along with other risk factors such as cancer and pregnancy. Dr David Keeling, Royal College of Physicians advisor and expert in DVT at the Oxford Haemophilia Centre and Thrombosis Unit, said the research was interesting. He also said that the activation of the coagulation system or excessive clotting of the blood b
'"/>




Page: 1 2

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Increased Heart Attack Risk From Celebrex,Vioxx
3. Allergy Risk Increased by Kerosene Use
4. Fewer teeth & Increased Ischemic Stroke risk
5. Young Smokers at Increased Risk Of Developing a Heart Attack
6. Women With Diabetes At Increased Risk Of Developing Cognitive Impairment
7. Asbestos Exposure Associated With An Increased Risk For Autoimmune Disease
8. Schizophrenics On Medication At An Increased Risk For Developing Diabetes
9. Diabetics Found To Be At An Increased Risk Of Developing Cancer
10. Increased Risk For Venous Thrombosis In Cancer Patients
11. Increased risk of common infections in patients suffering from diabetes
Post Your Comments:
(Date:12/2/2008)...Calif., Dec. 2 ,Attainia and The N...d they,will deploy Attainia,s suite of web-based ...rusts within the United Kingdom. , "NHSSC h...olutions for the,Hospital trusts in the United Ki... "We recognize that NHSSC is building one of the ...
(Date:12/2/2008)...wire/ -- TYRX, Inc., a leader in the development a...ducts, today announced the appointment of David El...for commercial operations. , , Mr. Elliot b...evice industry. Mr. Elliot joins TYRX from Valam C...g laser-based antimicrobial and vascular plaque de...
(Date:12/2/2008)...re/ -- BioIQ , the leader in consumer-friendly he..., who provides services that include wellness, hea...care management as well as case management of acut...loyers, and government agencies, will work togethe...rting tools as part of Alere,s Personal Health Sol...
(Date:12/2/2008)... form an integral part of most of,original equipm...ore become,essential for service providers in the...in competitive and constantly improve their servic...: http://www.newscom.com/cgi-bin/prnh/20081117/F...livan ( http://www.medicalimaging.frost.com ),Eur...
Breaking Medicine News(10 mins):Health News:The National Health Service and Attainia Move to Modernize Medical Capital Equipment Budgeting and Planning for the United Kingdom 2Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 2Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 3Health News:BioIQ and Alere to Provide At-Home Biometric Screening Tests to Employees 2Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 2Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 3
Washington’s governor has made a move that would please even his political// opponents. The bill is expected to extend health insurance to 38, 000 children in Washington. According to the go
... tea may help fight lung cancer, the leading cause... the world, shows a recent study//. Qing-Yi Lu, Ph...sity of California at Los Angeles (UCLA) and other...n lung cancer cells to a decaffeinated green tea e...
...in-Computer Interface (BCI) provides a new communi...puter//. Mental activity leads to changes of elect...ram (EEG) or Electrocorticogram (ECoG). The BCI sy...a control signal which can, for example, be used a...
...ent study indicates the negative impact of soft dr...niversity in Connecticut says that consumption// o...ty, diabetes and a host of other illnesses. Brown... 88 studies on this topic support a ban on the con...
Other Medicine News:Health News:More US Children to Be Covered by Health Insurance 2
(Date:12/1/2008)...wire-USNewswire/ -- New research has found that th...tomography (CT) scanner in an emergency room can s... who receive a potentially life-saving treatment. ...ical Center (NSMC)-Salem Hospital in Salem, Mass.,...the Radiological Society of North America (RSNA). ...
(Date:12/1/2008)... Vanda Pharmaceuticals In...ancet , one of the world,s leading medical journal...an regulator, experimental compound tasimelteon (V...s entitled "Melatonin agonist tasimelteon (VEC-162...wo randomised controlled multicentre trials." Resu...
(Date:12/1/2008)...wswire/ -- S*BIO Pte Ltd today announced the initi...otent and orally-active JAK2 inhibitor, in leading...ronic idiopathic myelofibrosis (CIMF). , , ...tolerability of SB1518 in patients with CIMF and i...1 part of the study will assess the safety profile...
(Date:12/1/2008)...phatasia Treated With ENB-0040 at Children,s Hospi... MONTREAL, Dec. 1 Enobia Pharma, a...eloping novel therapeutics for serious bone disord... in its clinical program for hypophosphatasia was ...Therapy (ERT) with ENB-0040 for the treatment of t...
Breaking Medicine Technology:Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Sea cucumbers fast track organ regrowth by healing their wounds 866 1Sea cucumbers fast track organ regrowth by healing their wounds 866 2Manor Care Shareholders Vote to Approve 246 3 Billion Carlyle Buyout 3989 1Manor Care Shareholders Vote to Approve 246 3 Billion Carlyle Buyout 3989 2Boston Scientific Announces New Initiatives to Increase Shareholder Value 3987 1Boston Scientific Announces New Initiatives to Increase Shareholder Value 3987 2Boston Scientific Announces New Initiatives to Increase Shareholder Value 3987 3Boston Scientific Announces New Initiatives to Increase Shareholder Value 3987 4Boston Scientific Announces New Initiatives to Increase Shareholder Value 3987 5DNC 3A With Orr Appointment Bush Republicans Put Partisan Ideology Ahead of Good Policy 3985 1
...INCOLNSHIRE, Ill.--(BUSINESS WIRE)--Jul 11, 2007 -...announced new positive,results demonstrating that ...cine adjuvant, BioVant(TM), may serve as an,effect... sparing,vaccine against H5N1 avian flu, widely kn...tudy using a hemagglutination,inhibition assay (HA...
...LEVERKUSEN, Germany - Biofrontera AG (DSE: B8F) an...esults in the dose finding part,of its phase IIb/I...LA, a gel that combines the active substance 5-ami...0, was strongly and significantly,superior to plac...ALA is used in photodynamic therapy, which elimina...
Other Medicine Technology:BioSante Pharmaceuticals Announces New Findings for Potential Bird,Flu Vaccine 2BioSante Pharmaceuticals Announces New Findings for Potential Bird,Flu Vaccine 3BioSante Pharmaceuticals Announces New Findings for Potential Bird,Flu Vaccine 4Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy,of BF-200 ALA In Actinic Keratosis 2
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
Medicine Products: